Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Peter Clifford is active.

Publication


Featured researches published by Peter Clifford.


The Lancet | 1970

CLONAL ORIGIN FOR INDIVIDUAL BURKTTT TUMOURS

P.J. Fialkow; George Klein; S.M. Gartler; Peter Clifford

Abstract The glucose-6-phosphate dehydrogenase (G.-6-P.D.) types of normal and malignant tissues were determined in seven patients with Burkitts lymphoma who were heterozygous at the G.-6-P.D. locus. Two enzyme types were observed in normal tissues, but only one type was found in each of 12 tumours. In one patient 4 distinct tumours were found to have the same single enzyme type. These observations are consistent with the suggestion that individual Burkitts tumours, and perhaps the entire disease process, has a clonal origin.


The Lancet | 1967

SURFACE IgM SPECIFICITY ON CELLS DERIVED FROM A BURKITT'S LYMPHOMA

George Klein; Jayshree J. Nadkarni; Hans Wigzell; Peter Clifford; Eva Klein; J.S Nadkarni

Abstract Burkitts lymphoma biopsy specimens from a 16-year-old African were found to differ from more than forty previously tested biopsy specimens from patients with this disease. Direct immunofluorescence detected a surface accumulation of IgM on living lymphoma cells, with a light-chain specificity. Anti-IgM or anti-light-chain sera killed the cells in the presence of complement even in high dilutions. Surface IgM specificity was maintained in three derived cell lines, grown in suspension for more than 4 months in vitro.


Cancer | 1967

Studies of burkitt lymphoma cells. I. Establishment of a cell line (B35M) and its characteristics

Jun Minowada; George Klein; Peter Clifford; Eva Klein; George E. Moore

A line of Burkitt lymphoma cells derived from a patient in Kenya, Africa, has been established in vitro. This cell line, designated B35M, consists of primitive lymphoblasts, and is similar to all lines of Burkitt lymphoma cells established previously by others. The doubling time of B35M cells in suspension culture is approximately 21 hours. The cells continuously synthesize human immunoglobulins. B35M cells harbor virus‐like particles that are indistinguishable by electron microscopy from those found in other lines of Burkitt lymphoma cells but attempts to identify the particles in B35M cells have been unsuccessful. The exact relationship of these particles to the host Burkitt Jymphoma cells is as yet undetermined.


Cancer | 1970

INCREASE IN ANTIBODY TITER AGAINST THE EBV-ASSOCIATED MEMBRANE ANTIGEN COMPLEX IN BURKITT'S LYMPHOMA AND NASOPHARYNGEAL CARCINOMA AFTER LOCAL IRRADIATION.

Nina Einhorn; George Klein; Peter Clifford

Sera of 2 African patients with Burkitts lymphoma and 3 with nasopharyngeal carcinoma were examined for antibodies against the EBV‐associated membrane antigen complex by titrating their blocking activity against an FITC‐conjugated reference immunoglobulin (F‐Mutua)derived from a case of Burkitts lymphoma in long‐term remission. The sera were tested beforeat the terminationand 6‐9 weeks after applying local radiotherapy to the tumor. Burkitt lymphoma‐derivedEBV‐carrying lymphoblastoid cell lines were used as target cells. Three patients with other tumors receiving radiotherapy served as controls (a case of Hodgkins diseaselaryngeal carcinoma and lymphosarcomarespectively). Six to 9 weeks after irradiation of the tumorthere was a significant increase in the titer of membrane‐reactive antibodiesin both cases of Burkitts lymphomaand in all 3 cases of nasopharyngeal carcinomabut not in the “control” tumors.


BMJ | 1963

Nitrogen Mustard Therapy with Aortic Occlusion in Nasopharyngeal Carcinoma

Peter Clifford; H. G. Oettgen; J. L. Beecher; F. P. Brown; J. R. Harries; W. E. Lawes

a supply of phisohex; to Messrs. Hough-Hoseason for supplies of ster-zac liquid soap and tegolan emulsion; to Mr. J. W. Hadgraft, of the Royal Free Hospital, for a supply of compound hexachlorophane cream; to British Drug Houses for a supply of dichlorophene; to Pearsons Antiseptic Company Limited for supplies of hycolin cream and liquid soap; to Willows Francis Limited for supplies of steriloderm and steriloderm forte; to Berk Pharmaceuticals Limited for a supply of betadine surgical scrub; and to Mrs. M. Kilner for secretarial assistance.


The Lancet | 1968

PLASMA-LEVELS OF THE SULPHATE ESTERS OF DEHYDROEPIANDROSTERONE AND ANDROSTERONE IN KENYAN MEN AND THEIR RELATION TO CANCER OF THE NASOPHARYNX

D.Y. Wang; R.D. Bulbrook; Peter Clifford

Abstract Plasma dehydroepiandrosterone-sulphate and androsterone-sulphate levels were determined in 40 Kenyan men. These levels were not correlated with age and were lower than those found in British men. Kenyans with nasopharyngeal cancers had significantly lower levels of plasma-dehydroepiandrosterone-sulphate than control Kenyans, although androsterone-sulphate levels were similar.


Acta Oncologica | 1976

Radiation Therapy of Nasopharyngeal Carcinoma in East Africa

L.-G. Larsson; Peter Clifford; J. Einhorn; B. Johansson; J. Onyango; Torsten Norin; A. de Schryver; R. Walstam

Results of irradiation, 1 to 3 years after treatment, are presented in 64 cases of nasopharyngeal carcinoma in East Africans. Two types of anatomic point indices are presented. Both correlate well with the results. Prophylactic irradiation of the mediastinum and both axillae was not followed by any evident improvement of the results.


Cancer Research | 1968

Surface IgM-kappa Specificity on a Burkitt Lymphoma Cell In Vivo and in Derived Culture Lines

Eva Klein; George Klein; Jagadish S. Nadkarni; Jayshree J. Nadkarni; Hans Wigzell; Peter Clifford


Journal of the National Cancer Institute | 1969

Antibodies to Epstein-Barr Virus in Burkitt's Lymphoma and Control Groups

Gertrude Henle; Werner Henle; Peter Clifford; Volker Diehl; George W. Kafuko; Barnabas G. Kirya; George Klein; Richard H. Morrow; Germano M. R. Munube; Patricia Pike; Peter M. Tukel; John L. Ziegler


Journal of the National Cancer Institute | 1970

Antibodies to Epstein-Barr Virus in Nasopharyngeal Carcinoma, Other Head and Neck Neoplasms, and Control Groups

Werner Henle; Gertrude Henle; Hung-Chiu Ho; Pierre Burtin; Yves Cachin; Peter Clifford; André de Schryver; G. De-Thé; Volker Diehl; George Klein

Collaboration


Dive into the Peter Clifford's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gertrude Henle

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Werner Henle

Children's Hospital of Philadelphia

View shared research outputs
Top Co-Authors

Avatar

Eva Klein

Karolinska Institutet

View shared research outputs
Top Co-Authors

Avatar

Surjit Singh

Kenyatta National Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

P.J. Fialkow

University of Washington

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ulla Gripenberg

Kenyatta National Hospital

View shared research outputs
Top Co-Authors

Avatar

John K. Duff

United States Department of Veterans Affairs

View shared research outputs
Researchain Logo
Decentralizing Knowledge